Literature DB >> 1458444

Cytogenetic studies in 112 cases of untreated myelodysplastic syndromes.

F Solé1, F Prieto, L Badia, S Woessner, L Florensa, M R Caballin, M D Coll, C Besses, J Sans-Sabrafen.   

Abstract

Cytogenetic studies were performed in 112 untreated cases of myelodysplastic syndrome (MDS) between 1985 and 1990. Among 112 patients who were examined at the time of diagnosis, 54 had an abnormal karyotype (48%). The highest frequency of chromosome abnormalities was observed in refractory anemia with excess of blasts (RAEB) and RAEB in transformation (RAEB-t) and the lowest in refractory anemia with ring sideroblasts (RARS) and chronic myelomonocytic leukemia (CMMoL). Numerical changes were observed in 19 cases and structural in 17; chromosome 8 was most frequently gained (11 cases), whereas chromosome 7 was most frequently lost (6 cases), 5q- in 14 (4 as a sole anomaly); involvement of 7q22 was seen in 3 cases, 11p in 2 patients, 11q in 3 (one patient as a sole anomaly), 12p in 4 (2 patients as a sole anomaly), i(17q) in 4 (3 patients as a sole anomaly), and complex chromosomal defects in 10 patients. If one takes into account the prognosis value, a complex karyotype and the presence of ring chromosomes were correlated with the worst prognosis, followed by -7/7q-; an intermediate prognosis corresponds to i(17q), 12p as a sole anomaly, +8 (as a sole anomaly or plus other anomalies), and involvement of 12p. Patients with a 5q- as a sole anomaly or with a normal karyotype, had the best prognosis.

Entities:  

Mesh:

Year:  1992        PMID: 1458444     DOI: 10.1016/0165-4608(92)90315-y

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  5 in total

Review 1.  Behcet's disease complicated with myelodysplastic syndrome: a report of two cases and review of the literature.

Authors:  K Yano; K Eguchi; K Migita; H Takashima; M Tamura; K Izumino; I Sasagawa; N Sadamori; S Nagataki
Journal:  Clin Rheumatol       Date:  1996-01       Impact factor: 2.980

2.  Acute myeloid leukemia with MYC rearrangement and JAK2 V617F mutation.

Authors:  Maro Ohanian; Carlos Bueso-Ramos; Chi Young Ok; Pei Lin; Keyur Patel; Mona Lisa Alattar; Joseph D Khoury; Uri Rozovski; Zeev Estrov; Yang O Huh; Jorge Cortes; Lynne V Abruzzo
Journal:  Cancer Genet       Date:  2015-06-25

3.  Cytogenetic findings in 179 patients with myelodysplastic syndromes.

Authors:  D Haase; C Fonatsch; M Freund; B Wörmann; H Bodenstein; H Bartels; B Stollmann-Gibbels; E Lengfelder
Journal:  Ann Hematol       Date:  1995-04       Impact factor: 3.673

4.  The CADM1 tumor suppressor gene is a major candidate gene in MDS with deletion of the long arm of chromosome 11.

Authors:  Marina Lafage-Pochitaloff; Bastien Gerby; Véronique Baccini; Laetitia Largeaud; Vincent Fregona; Naïs Prade; Pierre-Yves Juvin; Laura Jamrog; Pierre Bories; Sylvie Hébrard; Stéphanie Lagarde; Véronique Mansat-De Mas; Oliver M Dovey; Kosuke Yusa; George S Vassiliou; Joop H Jansen; Tobias Tekath; David Rombaut; Geneviève Ameye; Carole Barin; Audrey Bidet; John Boudjarane; Marie-Agnès Collonge-Rame; Carine Gervais; Antoine Ittel; Christine Lefebvre; Isabelle Luquet; Lucienne Michaux; Nathalie Nadal; Hélène A Poirel; Isabelle Radford-Weiss; Bénédicte Ribourtout; Steven Richebourg; Stéphanie Struski; Christine Terré; Isabelle Tigaud; Dominique Penther; Virginie Eclache; Michaela Fontenay; Cyril Broccardo; Eric Delabesse
Journal:  Blood Adv       Date:  2022-01-25

5.  A Case of Myelodysplastic Syndrome with Intestinal Behçet's Disease-Like Symptoms Treated by Prednisolone and Azacitidine.

Authors:  Masatsugu Endo; Akira Sekikawa; Takehiko Tsumura; Takanori Maruo; Yukio Osaki
Journal:  Am J Case Rep       Date:  2015-11-21
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.